Rituximab versus a watch-and-wait approach in patients with advanced-stage, asymptomatic, non-bulky follicular lymphoma: an open-label randomised phase 3 trial

Follicular Lymphoma International Prognostic Index

Blood · 2004 · 1.5K citations · Full text

Medicine, Hematology, Oncology +16

The Natural History of Initially Untreated Low-Grade Non-Hodgkin's Lymphomas

Sandra J. Horning, Saul A. Rosenberg · New England Journal of Medicine · 1984 · 911 citations

Medicine, Oncology, Hematologic Oncology +13

Normative data for the HADS from a large non‐clinical sample

Joanne Crawford, Julie D. Henry, Caroline Crombie et al. · British Journal of Clinical Psychology · 2001 · 821 citations · Full text

Social Sciences, Psychiatry, Psychology +17

Comparison in low-tumor-burden follicular lymphomas between an initial no-treatment policy, prednimustine, or interferon alfa: a randomized study from the Groupe d'Etude des Lymphomes Folliculaires. Groupe d'Etude des Lymphomes de l'Adulte.

Pauline Brice, Y Bastion, Éric Lepage et al. · Journal of Clinical Oncology · 1997 · 641 citations

Medicine, Hematology, Oncology +13

Prolonged treatment with rituximab in patients with follicular lymphoma significantly increases event-free survival and response duration compared with the standard weekly x 4 schedule

Michele Ghielmini · Blood · 2004 · 568 citations · Full text

Medicine, Immunology, Oncology +8